Katarina Sjögreen Gleisner
1 – 85 of 85
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs
(
- Contribution to journal › Article
-
Mark
A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE : Comparison of model implementations in SAAM II and MATLAB/SimBiology
(
- Contribution to journal › Article
-
Mark
3D printed non-uniform anthropomorphic phantoms for quantitative SPECT
(
- Contribution to journal › Article
-
Mark
Feasibility of 177Lu activity quantification using a small portable CZT-based gamma-camera
(
- Contribution to journal › Article
-
Mark
Pareto optimization of SPECT acquisition and reconstruction settings for 177Lu activity quantification
(
- Contribution to journal › Article
-
Mark
Retrospective evaluation of the predictive value of tumour burden at baseline [
68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT.
(
- Contribution to journal › Article
-
Mark
Accuracy of patient-specific I-131 dosimetry using hybrid whole-body planar-SPECT/CT I-123 and I-131 imaging
(
- Contribution to journal › Article
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
(
- Contribution to journal › Article
-
Mark
Physics for molecular radiotherapy – The battle between science and simplicity
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Averaging of absorbed doses : How matter matters
(
- Contribution to journal › Article
-
Mark
On the use of solid 133Ba sources as surrogate for liquid 131I in SPECT/CT calibration : a European multi-centre evaluation
(
- Contribution to journal › Article
-
Mark
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
EFOMP policy statement NO. 19 : Dosimetry in nuclear medicine therapy – Molecular radiotherapy
(
- Contribution to journal › Scientific review
-
Mark
The contest between internal and external-beam dosimetry : The Zeno's paradox of Achilles and the tortoise
2023) In Physica Medica(
- Contribution to journal › Scientific review
-
Mark
Implementation of dosimetry for molecular radiotherapy; results from a European survey
2023) In Physica Medica(
- Contribution to journal › Article
-
Mark
Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
(
- Contribution to journal › Article
-
Mark
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
(
- Contribution to journal › Article
-
Mark
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
(
- Contribution to journal › Article
-
Mark
Properties of the Digital Image
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Activity Quantification from Planar Images
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
(
- Contribution to journal › Article
-
Mark
Monte Carlo modelling of a compact CZT-based gamma camera with application to 177Lu imaging
(
- Contribution to journal › Article
- 2021
-
Mark
Peptide Receptor Radionuclide Therapy – Prospects for Personalised Treatment
(
- Contribution to journal › Article
-
Mark
Pituitary function after high-dose 177Lu-DOTATATE therapy and long-term follow-up
(
- Contribution to journal › Article
-
Mark
EANM dosimetry committee series on standard operational procedures : a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres
(
- Contribution to journal › Article
-
Mark
A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project
(
- Contribution to journal › Article
- 2020
-
Mark
Characterisation of a hand-held CZT-based gamma camera for 177Lu imaging
(
- Contribution to journal › Article
- 2019
-
Mark
Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
(
- Contribution to journal › Article
-
Mark
Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively
(
- Contribution to journal › Article
-
Mark
Re : Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma
(
- Contribution to journal › Letter
- 2018
-
Mark
Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals
(
- Contribution to journal › Article
-
Mark
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
(
- Contribution to journal › Article
-
Mark
3-D Image-Based Dosimetry in Radionuclide Therapy
(
- Contribution to journal › Scientific review
-
Mark
A method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation
(
- Contribution to journal › Article
-
Mark
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
(
- Contribution to journal › Article
-
Mark
From fixed activities to personalized treatments in radionuclide therapy : lost in translation?
(
- Contribution to journal › Article
- 2017
-
Mark
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
(
- Contribution to journal › Article
-
Mark
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
(
- Contribution to journal › Article
-
Mark
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy : The Devil Is in the Details
(
- Contribution to journal › Article
-
Mark
Variations in the practice of molecular radiotherapy and implementation of dosimetry : results from a European survey
(
- Contribution to journal › Article
-
Mark
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
(
- Contribution to journal › Article
-
Mark
Dosimetry-based treatment planning for molecular radiotherapy : A summary of the 2017 report from the Internal Dosimetry Task Force
(
- Contribution to journal › Scientific review
- 2016
-
Mark
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
(
- Contribution to journal › Article
-
Mark
Biologically effective dose in fractionated molecular radiotherapy-application to treatment of neuroblastoma with (131)I-mIBG.
(
- Contribution to journal › Article
-
Mark
Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer
(
- Contribution to journal › Article
-
Mark
Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
(
- Contribution to journal › Scientific review
-
Mark
Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.
(
- Contribution to journal › Article
-
Mark
Uncertainty propagation for SPECT/CT-based renal dosimetry in (177)Lu peptide receptor radionuclide therapy.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in (177)Lu-DOTATATE peptide receptor radionuclide therapy.
(
- Contribution to journal › Article
-
Mark
Long-term retention of 177Lu/177mLu-Dotatate in patients investigated by gamma spectrometry and gamma camera imaging.
(
- Contribution to journal › Article
- 2014
-
Mark
Testis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of (111)In-Ibritumomab Tiuxetan (Zevalin(®)).
(
- Contribution to journal › Article
- 2013
-
Mark
On the biologically effective dose (BED)-using convolution for calculating the effects of repair: I. Analytical considerations.
(
- Contribution to journal › Article
-
Mark
Dynamic (99m)Tc-MAG3 renography: images for quality control obtained by combining pharmacokinetic modelling, an anthropomorphic computer phantom and Monte Carlo simulated scintillation camera imaging.
(
- Contribution to journal › Article
-
Mark
On the biologically effective dose (BED)-using convolution for calculating the effects of repair: II. Numerical considerations.
(
- Contribution to journal › Article
- 2012
-
Mark
Patient-Specific Whole-Body Attenuation Correction Maps from a CT System for Conjugate-View-Based Activity Quantification: Method Development and Evaluation.
(
- Contribution to journal › Article
- 2011
-
Mark
Dosimetry in patients with B-cell lymphoma treated with [90Y]ibritumomab tiuxetan or [131I]tositumomab.
(
- Contribution to journal › Article
-
Mark
The accuracy of absorbed dose estimates in tumours determined by Quantitative SPECT: A Monte Carlo study.
(
- Contribution to journal › Article
-
Mark
Image-based patient-specific dosimetry for radionuclide therapy
2011) p.251-265(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2010
-
Mark
90Y Bremsstrahlung Imaging for Absorbed-Dose Assessment in High-Dose Radioimmunotherapy.
(
- Contribution to journal › Article
-
Mark
Lu-177-[DOTA0,Tyr3] Octreotate Therapy in Patients With Disseminated Neuroendocrine Tumors: Analysis of Dosimetry With Impact on Future Therapeutic Strategy
(
- Contribution to journal › Article
-
Mark
Extracorporeal techniques for improving radioimmunotherapy of disseminated malignant tumors
2010)(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results
2009) 6th Annual Conference of the European-Neuroendocrine-Tumor-Society In Neuroendocrinology 90(1). p.44-44(
- Contribution to journal › Published meeting abstract
-
Mark
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
(
- Contribution to journal › Article
-
Mark
Evaluation of quantitative planar (90)Y bremsstrahlung whole-body imaging.
(
- Contribution to journal › Article
-
Mark
Registration of serial SPECT/CT images for three-dimensional dosimetry in radionuclide therapy.
(
- Contribution to journal › Article
-
Mark
Development and evaluation of a pharmacokinetic model for prediction of radioimmunotherapy based on pretherapy data.
(
- Contribution to journal › Article
- 2008
-
Mark
Peptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results
2008) Twelfth Conference on Cancer Therapy with Antibodies and Immunoconjugates In Cancer Biotherapy and Radiopharmaceuticals 23(4). p.524-525(
- Contribution to journal › Published meeting abstract
-
Mark
Consequences of Inadvertent Radioiodine Treatment of Graves' Disease and Thyroid Cancer in Undiagnosed Pregnancy. Can We Rely on Routine Pregnancy Testing?
(
- Contribution to journal › Article
-
Mark
Evaluation of quantitative (90)Y SPECT based on experimental phantom studies.
(
- Contribution to journal › Article
- 2007
-
Mark
Parametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling
(
- Contribution to journal › Article
- 2005
-
Mark
The LundADose Method for Planar Image Activity Quantification and Absorbed-Dose Assessment in Radionuclide Therapy.
(
- Contribution to journal › Article
-
Mark
A new method to obtain transmission images for planar whole-body activity quantification.
(
- Contribution to journal › Article
- 2003
-
Mark
3D absorbed dose calculations based on SPECT: Evaluation for 111-In/90-Y therapy using Monte Carlo simulations.
(
- Contribution to journal › Article
- 2002
-
Mark
A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.
(
- Contribution to journal › Article
-
Mark
An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I.
(
- Contribution to journal › Article
- 2001
-
Mark
Registration of emission and transmission whole-body scintillation-camera images
(
- Contribution to journal › Article
-
Mark
Image Processing for Quantitative Scintillation-Camera Imaging. Application to Radionuclide Therapy.
2001)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas
(
- Contribution to journal › Article
- 1998
-
Mark
Boundary finding using Fourier surfaces of increasing order
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Deformable Fourier surfaces for volume segmentation in SPECT
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1997
-
Mark
Registration of abdominal CT and SPECT images using Compton scatter data
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1996
-
Mark
Biodistribution and pharmacokinetics of 125I/131I pair-labelled biotinylated chimeric BR96 in colon carcinoma isografted rats
(
- Contribution to journal › Article
- 1993
-
Mark
High resolution pinhole SPECT for tumor imaging
(
- Contribution to journal › Article